Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, et al.
Brain Sciences (2018) Vol. 8, Iss. 3, pp. 47-47
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

A systematic study of microdosing psychedelics
Vince Polito, Richard J. Stevenson
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0211023-e0211023
Open Access | Times Cited: 178
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
Thomas Anderson, Rotem Petranker, Daniel Rosenbaum, et al.
Psychopharmacology (2019) Vol. 236, Iss. 2, pp. 731-740
Closed Access | Times Cited: 134
New/emerging psychoactive substances and associated psychopathological consequences
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 30-42
Open Access | Times Cited: 94
Visual snow syndrome
Francesca Puledda, Christoph J. Schankin, Peter J. Goadsby
Neurology (2020) Vol. 94, Iss. 6
Open Access | Times Cited: 93
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Rita Kočárová, Jiřı́ Horáček, Robin Carhart‐Harris
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 68
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
Felix Müller, Elias Kraus, Friederike Holze, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1933-1943
Open Access | Times Cited: 49
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States
Charles L. Raison, Rakesh K. Jain, Andrew Penn, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 48
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D. Rosenblat, M. Ishrat Husain, Yena Lee, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 1, pp. 5-21
Open Access | Times Cited: 42
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
A framework for assessment of adverse events occurring in psychedelic-assisted therapies
Roman Palitsky, Deanna M. Kaplan, John Perna, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 690-700
Closed Access | Times Cited: 12
Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably?
Brian S. Barnett, Akhil Anand, Elizabeth N. Dewey, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 2, pp. 74-86
Closed Access | Times Cited: 9
Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 1
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 1
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders
Danilo De Gregorio, Justine P. Enns, Nicolás A. Núñez, et al.
Progress in brain research (2018), pp. 69-96
Closed Access | Times Cited: 79
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Richard J. Zeifman, Nikhita Singhal, Leah Breslow, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 436-451
Open Access | Times Cited: 45
Safety pharmacology of acute psilocybin administration in healthy participants
Isabelle Straumann, Friederike Holze, A. Becker, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104060-104060
Open Access | Times Cited: 7
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Visual Snow Syndrome: Proposed Criteria, Clinical Implications, and Pathophysiology
Abby I. Metzler, Carrie E. Robertson
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 8
Closed Access | Times Cited: 50
Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans
Paul Cumming, Milan Scheidegger, Dario A. Dornbierer, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2451-2451
Open Access | Times Cited: 37
Safety pharmacology of acute LSD administration in healthy subjects
Friederike Holze, Toya V. Caluori, Patrick Vizeli, et al.
Psychopharmacology (2021) Vol. 239, Iss. 6, pp. 1893-1905
Open Access | Times Cited: 37
Review of otential sychedelic reatments for PTSD
Ryan L. Henner, Matcheri S. Keshavan, Kevin P. Hill
Journal of the Neurological Sciences (2022) Vol. 439, pp. 120302-120302
Closed Access | Times Cited: 25
Apophenia, absorption and anxiety: Evidence for individual differences in positive and negative experiences of Hallucinogen Persisting Perceptual Disorder
Alexander Irvine, David Luke
Journal of Psychedelic Studies (2022) Vol. 6, Iss. 2, pp. 88-103
Open Access | Times Cited: 23
Abnormal Glutamatergic and Serotonergic Connectivity in Visual Snow Syndrome and Migraine with Aura
Francesca Puledda, Ottavia Dipasquale, Benjamin J. M. Gooddy, et al.
Annals of Neurology (2023) Vol. 94, Iss. 5, pp. 873-884
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top